Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
ITCI - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ITCI - Intra-Cellular Therapies, Inc.
106 M
LAST VALUE
-38.64%
2 YEAR CAGR
-4.75%
5 YEAR CAGR
53.36%
10 YEAR CAGR